FDA Section 4 \u2022 who must NOT take this

Dapagliflozin - Contraindications

These conditions, allergies, and situations mean Dapagliflozin should NOT be used. From the US FDA-approved drug label Section 4.

4 CONTRAINDICATIONS Dapagliflozin tablets are contraindicated in patients with a history of a serious hypersensitivity reaction to dapagliflozin or any of the excipients in dapagliflozin tablets.

Serious hypersensitivity reactions, including anaphylaxis and angioedema have been reported with dapagliflozin tablets [see Adverse Reactions ] .

History of serious hypersensitivity reaction to dapagliflozin or any of the excipients in dapagliflozin tablets.

Does any of this apply to YOU?

Ask Health AI \u2192